Postoperative Pain After Implementation of Standardized Pain Therapy Management in Orthopaedic Patients
Launched by SCHULTHESS KLINIK · Apr 9, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a standardized way of managing pain after surgery can help patients feel better and reduce the amount of pain medication they need. The study will focus on patients who are having major surgeries on their shoulders, hips, knees, or spine. By following a specific pain management plan, the researchers want to see how it affects recovery and pain levels for these different types of operations.
To be eligible for this study, patients must be undergoing certain surgeries, like hip or knee replacements, shoulder surgeries, or major spine surgeries. It's important that participants have signed consent forms to take part in the trial. While the study is not yet recruiting participants, those who join can expect to be monitored closely to understand how well the new pain management approach works compared to standard methods. This research aims to improve care for patients after surgery and help them recover more comfortably.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing primary hip and knee arthroplasties or revision surgery:CHOP Code: 81.51, 81.52, 81.52, 81.54
- • Patients undergoing primary shoulder or revision surgery: CHOP codes: 81.80.11, 81.80.12, 83.64.11, 81.82.35, 81.82.45, 81.82.46, 81.82.47
- • Patients undergoing major spine surgery: CHOP Code: 7A.6, 7A.7
- Exclusion Criteria:
- • - Patients who did not sign general informed consent (for the Schulthess Clinic).
About Schulthess Klinik
Schulthess Klinik is a renowned medical institution based in Zurich, Switzerland, specializing in orthopedic surgery and rehabilitation. With a commitment to advancing patient care through innovative research and clinical trials, the clinic is dedicated to enhancing treatment outcomes and improving quality of life for individuals with musculoskeletal conditions. Schulthess Klinik combines state-of-the-art technology with a multidisciplinary approach, fostering collaborations among healthcare professionals to ensure comprehensive care and support for patients. Its reputation for excellence in clinical research positions Schulthess Klinik as a leader in the field, contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Christoph K Hofer, MD
Principal Investigator
Schulthess Klinik
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported